IFIT2
Interferon-induced protein with tetratricopeptide repeats 2
Also known as: cig42, G10P2, GARG-39, IFI-54, IFI54, IFIT2_HUMAN, ISG-54, ISG-54K
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09913
- Gene
- IFIT2
- Ensembl
- ENSG00000119922
- Chromosome
- 10
- Canonical length
- 472 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables RNA binding activity. Involved in antiviral innate immune response and positive regulation of apoptotic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
472 residues, UniProt reviewed canonical sequence.
>P09913|IFIT2
1 MSENNKNSLE SSLRQLKCHF TWNLMEGENS LDDFEDKVFY RTEFQNREFK ATMCNLLAYL
61 KHLKGQNEAA LECLRKAEEL IQQEHADQAE IRSLVTWGNY AWVYYHMGRL SDVQIYVDKV
121 KHVCEKFSSP YRIESPELDC EEGWTRLKCG GNQNERAKVC FEKALEKKPK NPEFTSGLAI
181 ASYRLDNWPP SQNAIDPLRQ AIRLNPDNQY LKVLLALKLH KMREEGEEEG EGEKLVEEAL
241 EKAPGVTDVL RSAAKFYRRK DEPDKAIELL KKALEYIPNN AYLHCQIGCC YRAKVFQVMN
301 LRENGMYGKR KLLELIGHAV AHLKKADEAN DNLFRVCSIL ASLHALADQY EDAEYYFQKE
361 FSKELTPVAK QLLHLRYGNF QLYQMKCEDK AIHHFIEGVK INQKSREKEK MKDKLQKIAK
421 MRLSKNGADS EALHVLAFLQ ELNEKMQQAD EDSERGLESG SLIPSASSWN GELocalizationUniProt · AlphaFold · HPA
Whether an antibody against IFIT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 46 nTPM
- spinal cord: 28 nTPM
- spleen: 26 nTPM
- liver: 20 nTPM
- lung: 20 nTPM
- midbrain: 18 nTPM
Single-cell type
- pdcs: 469 nCPM
- epididymal clear cells: 241 nCPM
- endometrial luminal cells: 171 nCPM
- epididymal basal cells: 116 nCPM
- kupffer cells: 77 nCPM
- epididymal efferent duct ciliated cells: 63 nCPM
Immune cell
- neutrophil: 421 nTPM
- eosinophil: 108 nTPM
- basophil: 98 nTPM
- non-classical monocyte: 93 nTPM
- intermediate monocyte: 76 nTPM
- classical monocyte: 33 nTPM
Brain region
- spinal cord: 55 nTPM
- white matter: 33 nTPM
- medulla oblongata: 32 nTPM
- pons: 31 nTPM
- basal ganglia: 27 nTPM
- midbrain: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IFIT2.
Disease | ImmuneIEDB
Conditions an epitope on IFIT2 was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- apoptotic mitochondrial changes
- defense response to virus
- positive regulation of apoptotic process
- response to virus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IFIT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IFIT2 as an antibody target. Whether an autoantibody or antibody against IFIT2 could matter depends on whether native IFIT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IFIT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IFIT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...